Cargando…

In Silico Discovery and Subsequent Characterization of Potent 4R-Tauopathy Positron Emission Tomography Radiotracers

[Image: see text] A chemical fingerprint search identified Z3777013540 (1-(5-(6-fluoro-1H-indol-2-yl)pyrimidin-2-yl)piperidin-4-ol; 1) as a potential 4R-tau binding ligand. Binding assays in post-mortem Alzheimer’s disease (AD), progressive supranuclear palsy (PSP), and corticobasal degeneration (CB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Graham, Thomas J. A., Lindberg, Anton, Tong, Junchao, Stehouwer, Jeffrey S., Vasdev, Neil, Mach, Robert H., Mathis, Chester A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2023
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424182/ https://www.ncbi.nlm.nih.gov/pubmed/37487189 http://dx.doi.org/10.1021/acs.jmedchem.3c00775

Ejemplares similares

Radiosynthesis and Evaluation of [(11)C-Carbonyl]-Labeled Carbamates as Fatty Acid Amide Hydrolase Radiotracers for Positron Emission Tomography
por: Wilson, Alan A., et al.
Publicado: (2012)

Development of a Positron Emission Tomography Radiotracer for Imaging Elevated Levels of Superoxide in Neuroinflammation
por: Hou, Catherine, et al.
Publicado: (2017)

Positron Emission Tomography in Animal Models of Tauopathies
por: Cao, Lei, et al.
Publicado: (2022)

Novel positron emission tomography radiotracers in brain tumor imaging
por: D’Souza, Maria Mathew, et al.
Publicado: (2011)

Antibiotic‐Derived Radiotracers for Positron Emission Tomography: Nuclear or “Unclear” Infection Imaging?
por: Gouws, Arno Christiaan, et al.
Publicado: (2022)

Automation of a Positron-emission Tomography (PET) Radiotracer Synthesis Protocol for Clinical Production
por: Schopf, Eric, et al.
Publicado: (2018)

Preclinical dosimetry models and the prediction of clinical doses of novel positron emission tomography radiotracers
por: Garrow, Adam A., et al.
Publicado: (2020)

(18)F-THK5351 Positron Emission Tomography Imaging in Neurodegenerative Tauopathies
por: Ezura, Michinori, et al.
Publicado: (2021)

Amyloid and Tau Positron Emission Tomography Imaging in Alzheimer’s Disease and Other Tauopathies
por: Maschio, Cinzia, et al.
Publicado: (2022)

Identification of ABC Transporter Interaction of a Novel Cyanoquinoline Radiotracer and Implications for Tumour Imaging by Positron Emission Tomography
por: Slade, Rozanna L., et al.
Publicado: (2016)

Pyrazoles as Key Scaffolds for the Development of Fluorine-18-Labeled Radiotracers for Positron Emission Tomography (PET)
por: Gomes, Pedro M. O., et al.
Publicado: (2020)

Feasibility of TSPO-Specific Positron Emission Tomography Radiotracer for Evaluating Paracetamol-Induced Liver Injury
por: Kim, Daehee, et al.
Publicado: (2021)

Tau positron emission tomography imaging in tauopathies: The added hurdle of off-target binding
por: Lemoine, Laetitia, et al.
Publicado: (2018)

Tau Biomarkers in Dementia: Positron Emission Tomography Radiopharmaceuticals in Tauopathy Assessment and Future Perspective
por: Ricci, Maria, et al.
Publicado: (2021)

Fluorine-18 fluorodeoxyglucose positron emission tomography for cardiac sarcoidosis—is it time to consider a new radiotracer?
por: Christopoulos, Georgios, et al.
Publicado: (2017)

A Novel Substrate Radiotracer for Molecular Imaging of SIRT2 Expression and Activity with Positron Emission Tomography
por: Bonomi, Robin E., et al.
Publicado: (2018)

Positron emission tomography imaging of amyloid-beta plaque deposition: a decade of translation
por: Price, Julie C, et al.
Publicado: (2012)

Positron Emission Tomography Imaging of Macrophages in Atherosclerosis with (18)F-GE-180, a Radiotracer for Translocator Protein (TSPO)
por: Hellberg, Sanna, et al.
Publicado: (2018)

Highly specific noninvasive photoacoustic and positron emission tomography of brain plaque with functionalized croconium dye labeled by a radiotracer
por: Liu, Yajing, et al.
Publicado: (2017)

Positron emission tomography imaging for the assessment of mild traumatic brain injury and chronic traumatic encephalopathy: recent advances in radiotracers
por: Huang, Chu-Xin, et al.
Publicado: (2021)

Gallium-68 Labeling of the Cyclin-Dependent Kinase 4/6 Inhibitors as Positron Emission Tomography Radiotracers for Tumor Imaging
por: Liu, Cheng, et al.
Publicado: (2021)

The Synthesis and Evaluations of the (68)Ga-Lissamine Rhodamine B (LRB) as a New Radiotracer for Imaging Tumors by Positron Emission Tomography
por: Li, Xuena, et al.
Publicado: (2016)

Sodium-22-radiolabeled silica nanoparticles as new radiotracer for biomedical applications: in vivo positron emission tomography imaging, biodistribution, and biocompatibility
por: Al Faraj, Achraf, et al.
Publicado: (2015)

Development of a Novel Positron Emission Tomography (PET) Radiotracer Targeting Bromodomain and Extra-Terminal Domain (BET) Family Proteins
por: Bai, Ping, et al.
Publicado: (2020)

Characterization of neuroinflammatory positron emission tomography biomarkers in chronic traumatic encephalopathy
por: Varlow, Cassis, et al.
Publicado: (2022)

Cancer Research UK procedures in manufacture and toxicology of radiotracers intended for Pre-phase I positron emission tomography studies in cancer patients
por: Aboagye, E O, et al.
Publicado: (2002)

Can Gallium-68 Prostate-specific Membrane Antigen Ligand be a Potential Radiotracer for Renal Cortical Positron Emission Tomography Imaging?
por: Sarikaya, Ismet, et al.
Publicado: (2018)

Development of Novel Analogs of the Monocarboxylate Transporter Ligand FACH and Biological Validation of One Potential Radiotracer for Positron Emission Tomography (PET) Imaging
por: Sadeghzadeh, Masoud, et al.
Publicado: (2020)

Improved diagnostic accuracy of hybrid positron emission tomography (PET) with tumor-specific radiotracer for head and neck squamous cell carcinoma staging
por: Morand, Grégoire B., et al.
Publicado: (2023)

Computational Chemistry for the Identification of Lead Compounds for Radiotracer Development
por: Hsieh, Chia-Ju, et al.
Publicado: (2023)

Editorial: Positron Emission Tomography (PET) Imaging of Brain Biochemistry: Beyond High-Affinity Radioligands
por: Kilbourn, Michael R., et al.
Publicado: (2022)

Emerging PET Radiotracers and Targets for Imaging of Neuroinflammation in Neurodegenerative Diseases: Outlook Beyond TSPO
por: Narayanaswami, Vidya, et al.
Publicado: (2018)

Recent developments on PET radiotracers for TSPO and their applications in neuroimaging
por: Zhang, Lingling, et al.
Publicado: (2021)

Seizures are a druggable mechanistic link between TBI and subsequent tauopathy
por: Alyenbaawi, Hadeel, et al.
Publicado: (2021)

High-uptake areas on positron emission tomography with the hypoxic radiotracer (18)F-FRP170 in glioblastomas include regions retaining proliferative activity under hypoxia
por: Beppu, Takaaki, et al.
Publicado: (2015)

Automation of the Radiosynthesis of Six Different (18)F-labeled radiotracers on the AllinOne
por: Li, Shihong, et al.
Publicado: (2016)

Microfluidic radiosynthesis of [(18)F]FEMPT, a high affinity PET radiotracer for imaging serotonin receptors
por: Collier, Thomas Lee, et al.
Publicado: (2017)

Synthesis, in vitro and in vivo evaluation of (11)C-O-methylated arylpiperazines as potential serotonin 1A (5-HT(1A)) receptor antagonist radiotracers
por: Narayanaswami, Vidya, et al.
Publicado: (2020)

Basic physics of radiotracers
por: Barnes, W Earl
Publicado: (2017)

Positron Emission Tomography (PET) radiotracers in oncology – utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC)
por: Miele, Evelina, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_sv3sgmmbksm77sgacs1m8mkini